Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Geels

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Leukemia|October 10, 2025
Heart failure in patients with acute myeloid leukemia (AML) treated with anthracycline agents during remission induction therapy: a systematic review and meta-analysisJesse Geels, Anna van Rhenen, Patrycja Gradowska, et al.
Journal of the American College of Cardiology|April 8, 2026
Cardiovascular Disease Risk in Adults With Hematological Malignancies: A Population-Based Cohort Study Using Linked DatabasesJesse Geels, Anna van Rhenen, Clara Gomes, et al.
BMJ (Clinical Research Ed.)|September 23, 2025
Risk prediction models for cancer therapy related cardiac dysfunction in patients with cancer and cancer survivors: systematic review and meta-analysisClara Gomes, Jesse Geels, Thomas P A Debray, et al.
Cardio-Oncology (London, England)|January 28, 2025
Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxaneMarijke Linschoten, Jesse Geels, Erik van Werkhoven, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Leukemia|October 10, 2025
Heart failure in patients with acute myeloid leukemia (AML) treated with anthracycline agents during remission induction therapy: a systematic review and meta-analysisJesse Geels, Anna van Rhenen, Patrycja Gradowska, et al.
Journal of the American College of Cardiology|April 8, 2026
Cardiovascular Disease Risk in Adults With Hematological Malignancies: A Population-Based Cohort Study Using Linked DatabasesJesse Geels, Anna van Rhenen, Clara Gomes, et al.
BMJ (Clinical Research Ed.)|September 23, 2025
Risk prediction models for cancer therapy related cardiac dysfunction in patients with cancer and cancer survivors: systematic review and meta-analysisClara Gomes, Jesse Geels, Thomas P A Debray, et al.
Cardio-Oncology (London, England)|January 28, 2025
Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxaneMarijke Linschoten, Jesse Geels, Erik van Werkhoven, et al.
Pageof 1